Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
A new study that uncovers the original role of CRISPR’s scissors answers an evolutionary mystery and could lead to the discovery of better gene editing tools.
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.
Kevin L. Gardner, MD, PhD, has been named senior vice chair of the Department of Pathology and Cell Biology and professor of pathology and cell biology.